Newcastle Disease Virus 抗体
-
- 抗原 See all Newcastle Disease Virus (NDV) products
- Newcastle Disease Virus (NDV)
-
适用
- Newcastle Disease Virus (NDV)
-
宿主
- 小鼠
-
克隆类型
- 单克隆
-
标记
- This Newcastle Disease Virus antibody is un-conjugated
-
应用范围
- ELISA
- 产品特性
- Purified IgG
- 纯化方法
- Purified
- 免疫原
- Glycoprotein haemagglutinin-neuraminidase of Newcastle Disease Virus (La-Sota strain)
- 克隆位点
- 9F7
- 亚型
- IgG1
-
-
- 应用备注
- Optimal working dilution should be determined by the investigator.
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- 1.0 mg/mL
-
-
Phase 1 clinical experience using intravenous administration of PV701, an oncolytic Newcastle disease virus." in: Current cancer drug targets, Vol. 7, Issue 2, pp. 157-67, (2007) (PubMed).
: "
-
Phase 1 clinical experience using intravenous administration of PV701, an oncolytic Newcastle disease virus." in: Current cancer drug targets, Vol. 7, Issue 2, pp. 157-67, (2007) (PubMed).
-
- 抗原
- Newcastle Disease Virus (NDV)
- 别名
- NEWCASTLE DISEASE VIRUS (NDV 产品)
- 物质类
- Virus
- 背景
- Synonyms: NDV
-